An interventional study of Sleepiz One+ vs. polysomnography in Sleep Apnea, sponsored by Sleepiz AG. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-25.
Sponsored by Sleepiz AG · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 58 studies in Sleep Apnea Syndromes with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Sleep Apnea Syndromes · Germany.
Among the 58 studies in Sleep Apnea Syndromes with a site in Germany, this one is the 11th largest by enrollment of the 29 interventional ones that give a count, is one of 2 that started in 2020, is one of 21 with no phase, and was the 53rd registered.
1,085 studies on the registry are indexed under Sleep Apnea Syndromes; 172 are open to participants now.
Browse Sleep Apnea Syndromes studies →4 of the 58 studies in Sleep Apnea Syndromes with a site in Germany are open now. Recruiting first, the newest first:
Inspire Medical Systems, Inc. · Sites in Germany, Austria, Belgium and 4 more countries
Ages 18+
Technische Universität Dresden · Sites in Germany
Ages 18+
Christina Berr. MD · Sites in Germany
Ages 18+
Johannes Gutenberg University Mainz · Sites in Germany
Ages 18–120
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 119 Sleep Apnea Syndromes studies recruiting now, 58 (49%) set no upper age limit and 37 (31%) stop at 75 or younger; 25 take children under 18; 28 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
58 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 2 started in 2020.
This study's enrollment of 116 is above the median of 60 across 674 interventional studies indexed under Sleep Apnea Syndromes.
Median enrollment 60 across the 29 interventional studies, 200 across the 29 observational. Of the 37 that completed or were terminated, 8 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
24 of 58 have an industry lead sponsor. The 10 most frequent:
Sleepiz AG is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Sleepiz AG has 5 studies filed under Sleep Apnea Syndromes — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 58 studies in Sleep Apnea Syndromes with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Sleepiz One+ vs. polysomnography
Device: Sleepiz One+ vs. polysomnography
Simultaneous sleep recording with polysomnography and Sleepiz One+ device
Binary classification of subjects based on their sleep apnea severity (AHI ≥= 15) made by Sleepiz One+, compared to PSG data manually scored by sleep technicians
Time frame: 1 Night
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2020 to primary completion in Dec 2021, 12 months.
Of 69 industry-sponsored interventional studies with no phase under Sleep Apnea Syndromes, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 18. This study's 12 months is close to that.
Counting every sponsor, half of 271 studies reached it within 26 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleepiz AG